Cargando…
Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study
Autores principales: | Martínez-Montoro, José Ignacio, Picón-César, María José, Simón-Frapolli, Víctor José, Pinzón-Martín, José Luis, García-Alemán, Jorge, Durán-Martínez, María, Tinahones, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154648/ https://www.ncbi.nlm.nih.gov/pubmed/36884283 http://dx.doi.org/10.2337/dc23-0083 |
Ejemplares similares
-
Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2022) -
Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study
por: Martinho, António C.-V., et al.
Publicado: (2021) -
Creating Composite Indices From Continuous Variables for Research: The Geometric Mean
por: Gerstein, Hertzel C., et al.
Publicado: (2021) -
Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2021) -
“Triple-negative” non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease
por: Martínez-Montoro, José Ignacio, et al.
Publicado: (2022)